The Bio Investor Forum: Business Development Opportunities In Life Sciences.

Image taken from: http://www.mdtechcouncil.com/membership/events/calendar/bio-investor-forum/ 

 Date: 17 – 18 October 2018

Place: San Francisco, California

About the Forum

An investor forum to explore investment trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2019. Because our mission is to support industry-wide success, we strive to present a broad and unbiased view of investment opportunities.

The BIO Investor Forum delivers a rich program that features corporate presentations and panel debates on the sweet spots and growth challenges facing the industry.  The BIO Investor Forum features:

• ·         Public and venture-stage company presentations.
• ·         Expert-led panel discussions on the latest market and investment opportunities with the emphasis on drug and technology development.
• ·         BIO One-on-One Partnering™ meetings between biopharma executives and investors
• ·         Premier the opportunity to network with industry executives and investors focused exclusively on life sciences.

Some of the Key topics on the agenda

• ·         Navigating Checkpoint Inhibitors’ Clinical Results: Lessons for CEOs and Investors.
• ·         Learning from Translational Research Successes to Attract Investment.
• ·         Using Microbiome-Based Therapies to Improve Patient Outcomes.
• ·         Expanding the Toolbox of Neurodegeneration Therapies.
• ·         “Digiceuticals” as a New Class of FDA-Approved Therapeutics: Investment & Partnering Opportunities.

Who should attend?

The forum is open for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences.

Why you should not miss this event!

• ·         Hear from and meet with executives at the top life sciences growth companies.
• ·         Evaluate fresh investment opportunities including compatible, complementary and competitive companies.
• ·         Benefit from candid panel discussions with leading clinical experts and investigators with insights on pipeline research and clinical practice.
• ·         Get a ‘big picture’ overview of the industry and the issues affecting product innovation, capitalization, and commercialization
• ·         Meet one-on-one with new and current investors, analysts, and partnering companies.
• ·         Get the pulse on the latest life sciences investment trends from sophisticated investment and company executives.
• ·         Showcase your company story in presentations to qualified investors.
• ·         Network with peers, investors and potential partners.

For more information and registration: https://www.bio.org/events/bio-investor-forum

See also: The Bio+ Tech18 Conference: Innovation with Global Impact